MYLC2PL Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-86719
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the N-terminal region of Human MYLC2PL. Peptide sequence: ARKRAEGTASSNVFSMFDQSQIQEFKESLALSPRLERNGMISAHCNLCLT The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for MYLC2PL Antibody
![Western Blot: MYLC2PL Antibody [NBP2-86719]](https://resources.bio-techne.com/images/products/MYLC2PL-Antibody-Western-Blot-NBP2-86719-img0001.jpg "Western Blot: MYLC2PL Antibody [NBP2-86719]")
Western Blot: MYLC2PL Antibody [NBP2-86719]
Western Blot: MYLC2PL Antibody [NBP2-86719] - Host: Rabbit. Target Name: MYL10. Sample Type: 721_B Whole Cell lysates. Antibody Dilution: 1.0ug/mlMYL10 is supported by BioGPS gene expression data to be expressed in 721_BApplications for MYLC2PL Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: MYLC2PL
Alternate Names
MYLC2PLMGC3479, Myosin light chain 2, lymphocyte-specific, myosin regulatory light chain 10, myosin, light chain 10, regulatory, PLRLCmyosin light chain 2, precursor lymphocyte-specific, Precursor lymphocyte-specific regulatory light chain
Gene Symbol
MYL10
Additional MYLC2PL Products
Product Specific Notices for MYLC2PL Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...